Treatment

QX1206 clinical trials

1 indexed studies · 1 currently recruiting

RecruitingPHASE1
A Phase 1b Study of QX1206 in T2DM Patients With NAFLD
This study is looking at a new drug, QX1206, for people with type 2 diabetes and fatty liver disease. It aims to find the right dose and see if it helps improve their health.
For: Type 2 Diabetes Mellitus (T2DM) · Non-Alcoholic Fatty Liver Disease (NAFLD)
Canada